Effect of exercise on markers of inflammation in breast cancer survivors: The yale exercise and survivorship study

Cancer Prevention Research

Volumn 6, Issue 2, 2013, Pages 109-118

  Jones, Sara B ^a   Thomas, Gwendolyn A ^a   Hesselsweet, Sara D ^a   Alvarez Reeves, Marty ^b   Yu, Herbert ^a   Irwin, Melinda L ^a  

^a YALE UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AEROBIC EXERCISE; AGED; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVOR; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE INTENSITY; FAT BODY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PEDOMETRY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ADULT; AGED; BIOLOGICAL MARKERS; BREAST NEOPLASMS; C-REACTIVE PROTEIN; CARCINOMA; EXERCISE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MIDDLE AGED; SURVIVAL RATE; SURVIVORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874501476     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0278     Document Type: Review

References (64)

1. American Cancer Society. Cancer statistics presentation. Atlanta, GA: American Cancer Society, Inc.; 2011. p. 1-60.
2. Bardia A, Arieas E, Zhang Z, Defilippis A, Tarpinian K, Jeter S, et al. Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer. Breast Cancer Res Treat 2012;131:907-14.
3. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
4. Visser M, Bouter LM, McQuillanGM, Wener MH, Harris TB. Elevated Creactive protein levels in overweight and obese adults. JAMA 1999;282:2131-5.
5. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
6. Knüpfer H, Preiss R. Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat 2007;102:129-35.
7. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009;27:3437-44.
8. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB. Leisuretime physical activity and reduced plasma levels of obesity-related inflammatory markers. Obesity Res 2003;11:1055-64.
9. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444:860-7.
10. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:2308.
11. Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, et al. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 2005;23:774-82.
12. Handbooks I, Prevention C. Weight control and physical activity. In: Vainio H, Bianchini F, editors.Control. International Agency for Research on Cancer/World Health Organization; Lyon, France, 2002. p. 83-206.
13. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 2012;104:815-40.
14. Löf M, Bergström K, Weiderpass E. Physical activity and biomarkers in breast cancer survivors: a systematic review. Maturitas, Elsevier Ireland Ltd.; Elsevier House, Brookvale Plaza, East Park Shannon, Co. Clare, Irelande, 2012.
15. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-43.
16. Nicolini A, Carpi A, Rossi G. Cytokines in breast cancer. Cytokine Growth Factor Rev 2006;17:325-37.
17. Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nature reviews. Cancer 2008;8:887-99.
18. Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, et al. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 2003;103:642-6.
19. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol 2005;78:819-35.
20. Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego MS, Grassi MG, et al. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeost Agents 1992;6:103-7.
21. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 2007;61:824-33.
22. Christiansen T, Paulsen SK, Bruun JM, Pedersen SB, Richelsen B. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. Am J Physiol Endocrinol Metab 2010;298:E824-31.
23. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005;98:1154-62.
24. McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 2001;41:64-9.
25. Adamopoulos S, Parissis J, Karatzas D, Kroupis C, Georgiadis M, Karavolias G, et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol 2002;39:653-63.
26. Conraads VM, Beckers P, Bosmans J, De Clerck LS, Stevens WJ, Vrints CJ, et al. Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J 2002;23:1854-60.
27. Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 2005;100:93-9.
28. Petersen AM, Pedersen BK. The role of IL-6 in mediating the antiinflammatory effects of exercise. J Physiol Pharmacol 2006;57(Suppl 1):43-51.
29. Friedenreich CM, Woolcott CG, McTiernan A, Terry T, Brant R, Ballard- Barbash R, et al.. Adiposity changes after a 1-year aerobic exercise intervention among postmenopausal women: a randomized controlled trial. Int J Obes (Lond) 2011;35:427-35.
30. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007;14:189-206.
31. Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, De Pergola G. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord 2001;25:1416-20.
32. Fischer CP, Berntsen A, Perstrup LB, Eskildsen P, Pedersen BK. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 2007;17:580-7.
33. Gomez AM, Martínez C, Fiuza-Luces C, Herrero F, Perez M, Madero L, et al. Exercise training and cytokines in breast cancer survivors. Int J Sports Med 2011;32:461-7.
34. Hutnick NA, Williams NI, Kraemer WJ, Orsega-Smith E, Dixon RH, Bleznak AD, et al. Exercise and lymphocyte activation following chemotherapy for breast cancer. Med Sci Sports Exercise 2005;37:1827-35.
35. Janelsins MC, Davis PG, Wideman L, Katula JA, Sprod LK, Peppone LJ, et al. Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors. Clin Breast Cancer 2011;11:161-70.
36. Payne J, Piper B, Rabinowitz I, Zimmerman B. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study. Oncol Nurs Forum 2006;35:635-42.
37. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Martin BS, et al. Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial. Brain Behav Immun 2005;19:381-8.
38. Irwin ML, Cadmus L, Alvarez-Reeves M, O'Neil M, Mierzejewski E, Latka R, et al. Recruiting and retaining breast cancer survivors into a randomized controlled exercise trial: the Yale Exercise and Survivorship Study. Cancer 2008;112(11 Suppl):2593-606.
39. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs- Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178-87.
40. Irwin ML, Tworoger SS, Yasui Y, Rajan B, McVarish L, LaCroix K, et al. Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. Preventive Med 2004;39:1080-6.
41. Bassett DR, Ainsworth BE, Leggett SR, Mathien CA, Main JA, Hunter DC, et al. Accuracy of five electronic pedometers for measuring distance walked. Med Sci Sports Exercise 1996;28:1071-7.
42. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exercise 2000;32 (9 Suppl):S498-504.
43. Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 2001;47:403-11.
44. Hoeger WWK, Bond L, Ransdell L, Shimon JM, Merugu S. One-mile step count at walking and running speeds. ACSM's Health Fitness J 2008;12:14-9.
45. Nicklas BJ, You T, Pahor M. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. Can Med Assoc J 2005;172:1199-209.
46. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR, et al. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol 2005;98:1534-40.
47. Irwin M, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship Study. Cancer Epidemiol Biomarkers Prev 2009; 18:306-313.
48. Dekker MJ, Lee S, Hudson R, Kilpatrick K, Graham TE, Ross R, et al. An exercise intervention without weight loss decreases circulating interleukin- 6 in lean and obese men with and without type 2 diabetes mellitus. Metab Clin Exp 2007;56:332-8.
49. Giannopoulou I, Fernhall B, Carhart R, Weinstock RS, Baynard T, Figueroa A, et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metab Clin Exp 2005;54:866-75.
50. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA 2003;289:1799-804.
51. Olson TP, Dengel DR, Leon AS, Schmitz KH. Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond) 2007;31:996-1003.
52. Hammett CJK, Oxenham HC, Baldi JC, Doughty RN, Ameratunga R, French JK, et al. Effect of six months' exercise training on C-reactive protein levels in healthy elderly subjects. J Am Coll Cardiol 2004; 44:2411-3.
53. Huffman KM, Slentz CA, Bales CW, Houmard JA, Kraus WE. Relationships between adipose tissue and cytokine responses to a randomized controlled exercise training intervention. Metab Clin Exp 2008;57:577-83.
54. Kohut ML, McCann DA, Russell DW, Konopka DN, Cunnick JE, Franke WD, et al. Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of [beta]-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 2006;20:201-9.
55. Nicklas BJ, Ambrosius W, Messier SP, Miller GD, Penninx BW, Loeser RF, et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 2004;79:544-51.
56. Oberbach A, Tönjes A, Klöting N, Fasshauer M, Kratzsch J, Busse MW, et al. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 2006;154:577-85.
57. Kasapis C, Thompson PD. The effects of physical activity on serum Creactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005;45:1563-9.
58. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338-42.
59. Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord 2003;27(Suppl 3): S25-8.
60. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001;60:349-56.
61. Pritchard KI, Shepherd LE, Chapman JA, Norris BD, Cantin J, Goss PE, et al. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14. J Clin Oncol 2011;29:3869-76
62. Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, et al. A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women. Breast Cancer Res Treat 2010; 120:427-35
63. Mrozek E, Layman R, Ramaswamy B, Schaaf L, Li X, Ottman S, et al. Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with advanced, hormone-responsive breast cancer. Clin Breast Cancer 2012;12:151-6
64. Robidoux A, Rich E, Bureau N, Mader S, Laperriere D, Bail M, et al. A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitory therapy. Curr Oncol 2011;18:285-92.